INVIVOSIM
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Sept 2026)
What this means for you
Registered since 03 Nov 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Nov 2030: the §8 & §9 renewal).
Record
- Serial number
- 88878733
- Registration number
- 6189508
- Mark type
- Word mark
- Filed
- 20 Apr 2020
- Published for opposition
- 18 Aug 2020
- Registered
- 03 Nov 2020
- Next maintenance filing
- §8 & §9 renewal, due by 03 Nov 2030 (grace period to 03 May 2031)
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 001 — Chemicals: Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
Owner
- BIO X CELL, LLC, LEBANON, NH, US
- Bio X Cell, Lebanon, NH, US
- Bio X Cell, Lebanon, NH, US
- Bio X Cell, Lebanon, NH, US
Prosecution history
- 13 Sept 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Sept 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Sept 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Jun 2026 — TEAS SECTION 8 & 15 RECEIVED
- 03 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Dec 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 29 Nov 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Nov 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Nov 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 18 Aug 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Aug 2020 — PUBLISHED FOR OPPOSITION
- 29 Jul 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jul 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jul 2020 — ASSIGNED TO EXAMINER